Dr. Berry is the Associate Chief of Clinical Neurotherapeutics at Massachusetts General Hospital, where he also leads the Division of ALS and Motor Neuron Diseases.  He is a dedicated ALS clinical researcher, with a focus on biomarker development and ALS clinical trial methodology.  He is an advocate for Open Science and oversees a large biorepository, sharing samples and clinical information with researchers around the globe to facilitate critical ALS research and drug development. He also leads projects developing digital outcome measures for ALS trials that will help increase the objective data collection and decrease participant burden.  Finally, he is deeply committed to developing novel therapeutics by translating discoveries in the lab into clinical trials and leading clinical trials that will transform our approach to care in ALS.

Dr. Berry also oversees the clinic at the Healey Center for ALS, caring for patients and overseeing the multidisciplinary care team with the clinic co-director, Jen Scalia, NP.  He is committed to providing innovative care to meet the needs of people with ALS.  In 2011, he helped found a telemedicine program for People with ALS (TelePALS), and has since founded the ALS House Call Program and the Parenting at a Challenging Time (PACT) programs within the ALS clinic.